- Entry
- $4.69
- Final
- $3.30 -29.6%
- Target
- —
- Score
- -1.00
https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-severe-leukocyte-adhesion-deficiency-type-i This information dropped around 7 PM Thursday evening regarding their drug Kresladi. Let’s see what this thing does in the morning!
— ORIGINAL POST ·
Rocket pharmaceuticals gets FDA approval (RCKT)
· r/investing
· Mar 27, 2026